Hirsutism clinical trials
The registry lists 41 studies for Hirsutism across more than 10 countries. 8 are recruiting or about to start. 18 of them are mainly about Hirsutism (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-30.
Get an email when these change. Save the Hirsutism studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Corcept Therapeutics (3) · Odense University Hospital (3) · Scilex Ltd. (2) · Columbia University (2) · Sandoz (2) · Follicum AB (1) · Allergan (1) · Center for Epidemiology and Health Research, Germany (1)
What is being tested here
Drugs under test in Hirsutism studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Magnesium | 1 | 0 | 1 |
| Carnitine | 1 | 0 | 1 |
| Eflornithine | 0 | 0 | 2 |
| Bicalutamide | 0 | 0 | 2 |
| Mifepristone | 0 | 2 | 2 |
| Metformin | 0 | 0 | 2 |
| Flutamide | 0 | 0 | 1 |
| Inositol | 0 | 0 | 1 |
| Tyrosine | 0 | 0 | 1 |
| Pavinetant | 0 | 0 | 1 |
Drug classes tested here Antiandrogens 4
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Dec 2026Treatment of Hypertrichosis With Intense Pulsed Light · Alexander Shayesteh
Who these studies take
Of the 7 Hirsutism studies recruiting now, 2 (29%) set no upper age limit and 5 (71%) stop at 75 or younger. 1 (14%) take children under 18. 5 (71%) are for women only and 0 (0%) for men only; 2 (29%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 5 (71%) | 2 (29%) |
| 30 | 6 (86%) | 2 (29%) |
| 40 | 6 (86%) | 2 (29%) |
| 50 | 3 (43%) | 2 (29%) |
| 65 | 3 (43%) | 2 (29%) |
| 75 | 2 (29%) | 2 (29%) |
| 85 | 2 (29%) | 2 (29%) |
Across all 41 studies, recruiting or not: 71% stop at 75 or younger and 66% at 65; 32% take children; 71% are for women only and 7% for men only; 41% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 41 of 41. search them.
- Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS)RecruitingNCT07780188Not applicable1 country
- Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)RecruitingNCT07298564Not applicable1 country
- Comparison of a Face Cream Plus a Laser Procedure and Face Cream Alone in Treatment of Excessive Face Hairs in FemaleRecruitingNCT06976424Phase 41 country
- Treatment of Hypertrichosis With Intense Pulsed LightRecruitingNCT057753281 country
- Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin DisorderRecruitingNCT06655129Not applicable1 country
- The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary SyndromeRecruitingNCT06642363Phase 11 country
- Suppression of Upper Lip Hair Growth Using Novel Hemp ExtractNot yet recruitingNCT06003062
- Phenotype and Epidemiology of the Polycystic Ovary Syndrome (PCOS) in Colombia (PEP - Colombia) Study.RecruitingNCT059261151 country
- NAFLD in Adolescents and Young Adults With PCOSSuspendedNCT025069461 country
- Diagnostics of Clinical HyperandrogenismCompletedNCT065304981 country
- Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)TerminatedNCT02500147Phase 41 country
- Prevalence of Hyperandrogenism in Type 1 DiabetesCompletedNCT049793771 country
- Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS WomenCompletedNCT01889199Phase 21 country
- To Comapre The Effectiveness of Two Lasers in The Treamment of Unwanted HairCompletedNCT05739799Not applicable1 country
- The Effect of Polycystic Ovary Syndrome Treatment on MetabolomicsStatus unknownNCT04831151Not applicable1 country
- DUS on the Prescribing Indications for CPA/EE in 5 European CountriesCompletedNCT024942971 country
- MLE4901 vs. Placebo for the Treatment of PCOSTerminatedNCT02865915Phase 21 country
- Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol AloneCompletedNCT01555190Not applicable1 country
- Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOSCompletedNCT03673995Not applicable1 country
- Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study GroupStatus unknownNCT042925871 country
- Evaluation of Eflornithine on Facial and Forearm SkinCompletedNCT00152048Phase 4
- Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS)TerminatedNCT02052479Not applicable1 country
- Clinical Evaluation of Silk'n Glide for FaceCompletedNCT02103608Not applicable
- Investigation of FOL-005 on Clinical Safety and Effect on Hair GrowthCompletedNCT02793557Phase 1/21 country
- Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting ConditionsCompletedNCT00959335Phase 1
- Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed ConditionsCompletedNCT00960310Phase 1
- A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of HypercortisolemiaTerminatedNCT007967831 country
- An Extension Study of CORLUX in the Treatment of Endogenous Cushing's SyndromeCompletedNCT00936741Phase 31 country
- Treatment With Topical Eflornithin After Laser Treatment in Women With Facial HirsutismCompletedNCT01817894Phase 41 country
- Obesity and Clinical Presentation of HyperandrogenismCompletedNCT011146331 country
- A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's SyndromeCompletedNCT00569582Phase 31 country
- Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite LaserStatus unknownNCT01461694Phase 2/31 country
- Metabolic and Endocrine Status in Women With Prior Preterm BirthCompletedNCT013555361 country
- Database Study on Patients With PCOSStatus unknownNCT013385191 country
- Bone Status and Insulin Resistance in HirsutismCompletedNCT001430521 country
- Photodynamic Therapy for Permanent Hair RemovalStatus unknownNCT00371930Phase 1/21 country
- Topical Finasteride in the Treatment of Idiopathic HirsutismCompletedNCT00564252Not applicable
- Enhanced Safety Aesthetic Laser SystemStatus unknownNCT00495443Not applicable1 country
- Prospective Study of Patients With HirsutismStatus unknownNCT001452881 country
- Enhanced Safety Laser Hair Removal SystemStatus unknownNCT00441948Not applicable1 country
- Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOSCompletedNCT00428311Phase 41 country